WHO ICTRP trial
Effect of supplementation in treatment of patients with diabetic hemodialysis
IRCT201603185623N69 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201603185623N69 |
|---|---|
| Public title | Effect of supplementation in treatment of patients with diabetic hemodialysis |
| Scientific title | Clinical trial of the effect of probiotic supplementation compared with the placebo on metabolic profiles in patients with diabetic hemodialysis |
| Primary sponsor | Vice chancellor for research, Kashan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | ?????????. Chronic kidney disease |
| Interventions | Intervention 1: Intervention group: Probiotic supplements containing three strains of Lactobacillus acidophilus (2×109 CFU/g), Lactobacillus casei (2×109 CFU/g) and Bifidobacterium bifidum (2×109 CFU/g), daily, for 12 weeks orally… |
| Registration date | Mar 23, 2016 |
| Target size | 60 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: